http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10876015
Outgoing Links
Predicate
Object
contentType
Journal Article
endingPage
329
issn
2352-3204
pageRange
322-329
publicationName
Regenerative Therapy
startingPage
322
bibliographicCitation
Xue Y, Xu T, Jiang W. Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381/LRRC4 /SDF-1/CXCR4 signaling pathway. Regenerative Therapy. 2020 Jun;14():322–9. doi: 10.1016/j.reth.2020.03.001.
creator
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6333c9771adba396c4f39e7015778d9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5868-4079
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31d936b8478e02a0f56147cdd56f22b4
date
202006
identifier
https://pubmed.ncbi.nlm.nih.gov/32467829
https://pubmed.ncbi.nlm.nih.gov/PMC7243045
https://doi.org/10.1016/j.reth.2020.03.001
isPartOf
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/47030
https://portal.issn.org/resource/ISSN/2352-3204
language
English
source
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title
Dexmedetomidine protects PC12 cells from ropivacaine injury through miR-381/LRRC4 /SDF-1/CXCR4 signaling pathway
discussesAsDerivedByTextMining
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4c8b63bc67442aae313608bc2f2ec83f
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_efd0e704b1d1a527d60f253b8e0d4b86
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175805
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b44167dbe59e45113786b6f6314ef
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_034e8f4842428b1bd8db28af167d55d8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311068
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10523
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.13.12.8
Total number of triples:
30
.